
CheckOrphan is the leading #news and information platform dedicated to #rarediseases and #orphandrugs
Santa Cruz, USA / Basel, CH
Joined April 2009
- Tweets30.2K
- Following5.2K
- Followers18K
- Likes11.1K
Merck’s Phase 3 TroFuse-015 Trial Shows Overall Survival Benefit for Sac-TMT in Advanced Gastroesophageal Adenocarcinoma - For More Information Visit tinyurl.com/3py5w9md @Merck #Rare_Diseases #Orphan_Drugs #Cancer_research #Cancer_drugs
39
Novo's Sogroya® Receives FDA Approval as the First and Only Once-Weekly, Long-Acting Growth Hormone for Children with Turner Syndrome (TS) - For More Information Visit tinyurl.com/2chesd24 @novonordiskus #FDA #Turner_Syndrome #Rare_Diseases #Orphan_Drugs
37
Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD) - For More Information Visit tinyurl.com/y6dx78a7 @PalvellaTX #EMPD #Paget_Disease #Rare_Diseases #Orphan_Drugs #Rare_Cancers
91
Bristol Myers Squibb Demonstrates Breadth and Clinical Momentum Across Blood Cancers and Rare Hematologic Disorders at ASH 2026 - For More Information Visit tinyurl.com/4npt3kd6 @bmsnews #Rare_Diseases #Orphan_Drugs #multiple_myeloma #Lymphomas
69
Opus Genetics Doses First Patient in Phase 1/2 Trial of OPGx-RDH12 Gene Therapy for RDH12-Associated Leber Congenital Amaurosis - For More Information Visit tinyurl.com/y2w2wnmz #Opus_Genetics #RDH12_LCA #Leber_Congenital_Amaurosis #Rare_Diseases #Orphan_Drugs
99
Off-Label Efgartigimod Helps Young Woman with Severe, Treatment-Resistant LEMS Regain Mobility and Independence - For More Information Visit tinyurl.com/33x6e3eu #Lambert_Eaton #LEMS #Rare_Diseases
GSK’s Velzatinib Receives Japan’s Orphan Drug Designation for Gastrointestinal Stromal Tumor Treatment (GIST) - For More Information Visit tinyurl.com/hs3hj826 @GSK @GSKUS #Rare_Diseases #GIST #Orphan_Drugs #Gastrointestinal_Stromal_Tumor #Cancer_research
Livsayis™ (cemdisiran), First FDA-Approved siRNA Therapy for Generalized Myasthenia Gravis Offering Convenient Quarterly Subcutaneous Dosing - For More Information Visit tinyurl.com/dw8bjea5 @Regeneron #FDA #gMG #Myasthenia_Gravis #Rare_Diseases #Orphan_Drugs
1
96
Inhibrx Reports 62.7% Overall Response Rate for Ozekibart Combination Therapy in Relapsed or Refractory Ewing Sarcoma - For More Information Visit tinyurl.com/yc5n3tj2 @inhibrx #Ewing_Sarcoma #Rare_Diseases #Orphan_Drugs #cancer_treatment
116
Karyopharm Announces FDA Acceptance of sNDA for XPOVIO® (selinexor) Plus Ruxolitinib for the Treatment of Patients with Myelofibrosis - For More Information Visit tinyurl.com/4y5d6cde @Karyopharm #Myelofibrosis #FDA #XPOVIO #Rare_Diseases #Orphan_Drugs
116
European Commission Approves Sobi’s Tryngolza as First RNA-Targeted Therapy for Severe Hypertriglyceridemia in the EU - For More Information Visit tinyurl.com/29z5vb9z #Sobi #Rare_Diseases #Orphan_Drugs #Severe_Hypertriglyceridemia #sHTG
127
Rare Cancers Publishes Case Report Detailing Eight-Year Response to Relacorilant Plus Nab-Paclitaxel in Metastatic Vulvar Cancer - For More Information Visit For More Information Visit tinyurl.com/yc742vkp #ESMO #Vulvar_Cancer #Corcept_Therapeutics #Rare_Cancers
126
Neurizon Announces First Participant Completes 36-Week Phase of HEALEY ALS Trial and Transitions to Active Treatment Extension - For More Information Visit tinyurl.com/47j4evmm @Neurizon_ltd #Rare_Diseases #ALS #Orphan_Drugs #Amyotrophic_Lateral_Sclerosis
128
Lexeo Therapeutics Reports Positive Interim Phase I/II Data for LX2020, Demonstrating Reduced Arrhythmia Burden in PKP2-ACM Patients - For More Information Visit tinyurl.com/5faf6v69 #Lexeo_Therapeutics #ACM #Arrhythmogenic_Cardiomyopathy #Rare_Diseases #Orphan_Drugs
99
Roche’s Gazyva/Gazyvaro Becomes the First FDA-Approved Treatment for Primary Membranous Nephropathy - For More Information Visit tinyurl.com/4n77jcsh @Roche #Rare_Diseases #Orphan_Drugs #pMN #FDA #Primary_Membranous_Nephropathy #kidney_Diseases #Gazyva
Novartis Receives Positive CHMP Opinion for Cosentyx® in Adolescents aged 12+ with Hidradenitis Suppurativa (HS) - For More Information Visit tinyurl.com/4p5twcjc @Novartis #CHMP #Rare_Diseases #Orphan_Drugs #Cosentyx #Hidradenitis_Suppurativa #Drug_Research
1
166
CHMP Recommends EU Approval of Roche’s Gazyva/Gazyvaro for Systemic Lupus Erythematosus (SLE) - For More Information Visit tinyurl.com/mr2b4zva @Roche #SLE #Systemic_Lupus_Erythematosus #CHMP #Rare_Diseases #Orphan_Drugs #Gazyva
Novo Submits Etavopivat, an Investigational Once-Daily Therapy for Adolescents and Adults Living with Sickle Cell Disease, to The FDA and EMA For Approval - For More Information Visit tinyurl.com/m64a6dcd @novonordiskus #FDA #EMA #Sickle_Cell_Disease #Rare_Diseases
3
181
Ionis Reports New Two-Year Data Showing Sustained 95% Reduction in Hereditary Angioedema Attacks with DAWNZERA at ACAAI 2026 Annual Meeting - For More Information Visit tinyurl.com/mtb4uesb @ionispharma #HAE #Hereditary_Angioedema #Rare_Diseases #Orphan_Drugs
Bexsero ( 4CMenB ) receives positive CHMP opinion for one-dose Meningitis B booster for 10+ year olds - For More Information Visit tinyurl.com/3edvvdrv @gskca #Meningitis_B #Meningitis #Rare_Diseases #CHMP
138


















